{"verbs": [{"verb": "provides", "description": "[ARG0: ironwood pharmaceuticals] [V: provides] [ARG1: third quarter 2018 investor update cambridge mass business wire -nov 6 2018-ironwood pharmaceuticals inc nasdaq bowel syndrome cambridge olinciguat ironwood constipation abdominal pain iw-3718 ironwood ironwood phase iia asymptomatic ironwood pharmaceuticals gerd diabetic nephropathy hfpef abdominal distension severe diarrhea cic zurampic u s olinciguat peter hecht praliciguat ironwood r&d co allergan nephropathy fda achalasia praliciguat ironwood renal disease ironwoods gaap ironwood gaap allopurinol ironwood pharmaceuticals inc astrazeneca iw 3718 ironwood olinciguat ironwood mass]", "tags": ["B-ARG0", "I-ARG0", "B-V", "B-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1"]}, {"verb": "inc", "description": "ironwood pharmaceuticals provides third quarter 2018 investor update cambridge mass business wire -nov 6 2018-ironwood pharmaceuticals [V: inc] nasdaq bowel syndrome cambridge olinciguat ironwood constipation abdominal pain iw-3718 ironwood ironwood phase iia asymptomatic ironwood pharmaceuticals gerd diabetic nephropathy hfpef abdominal distension severe diarrhea cic zurampic u s olinciguat peter hecht praliciguat ironwood r&d co allergan nephropathy fda achalasia praliciguat ironwood renal disease ironwoods gaap ironwood gaap allopurinol ironwood pharmaceuticals inc astrazeneca iw 3718 ironwood olinciguat ironwood mass", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-V", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "gerd", "description": "ironwood pharmaceuticals provides third quarter 2018 investor update cambridge mass business wire -nov 6 2018-ironwood pharmaceuticals inc nasdaq bowel syndrome cambridge olinciguat ironwood constipation abdominal pain iw-3718 ironwood ironwood phase iia asymptomatic ironwood pharmaceuticals [V: gerd] [ARG1: diabetic nephropathy hfpef abdominal distension severe diarrhea] cic zurampic u s olinciguat peter hecht praliciguat ironwood r&d co allergan nephropathy fda achalasia praliciguat ironwood renal disease ironwoods gaap ironwood gaap allopurinol ironwood pharmaceuticals inc astrazeneca iw 3718 ironwood olinciguat ironwood mass", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-V", "B-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "I-ARG1", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "hfpef", "description": "ironwood pharmaceuticals provides third quarter 2018 investor update cambridge mass business wire -nov 6 2018-ironwood pharmaceuticals inc nasdaq bowel syndrome cambridge olinciguat ironwood constipation abdominal pain iw-3718 ironwood ironwood phase iia asymptomatic ironwood pharmaceuticals gerd diabetic nephropathy [V: hfpef] [ARG1: abdominal distension] severe diarrhea cic zurampic u s olinciguat peter hecht praliciguat ironwood r&d co allergan nephropathy fda achalasia praliciguat ironwood renal disease ironwoods gaap ironwood gaap allopurinol ironwood pharmaceuticals inc astrazeneca iw 3718 ironwood olinciguat ironwood mass", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-V", "B-ARG1", "I-ARG1", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "ironwoods", "description": "ironwood pharmaceuticals provides third quarter 2018 investor update cambridge mass business wire -nov 6 2018-ironwood pharmaceuticals inc nasdaq bowel syndrome cambridge olinciguat ironwood constipation abdominal pain iw-3718 ironwood ironwood phase iia asymptomatic ironwood pharmaceuticals gerd diabetic nephropathy hfpef abdominal distension severe diarrhea cic zurampic u s olinciguat peter hecht praliciguat ironwood r&d co allergan nephropathy fda achalasia praliciguat ironwood renal disease [V: ironwoods] gaap ironwood gaap allopurinol ironwood pharmaceuticals inc astrazeneca iw 3718 ironwood olinciguat ironwood mass", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-V", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O"]}, {"verb": "inc", "description": "ironwood pharmaceuticals provides third quarter 2018 investor update cambridge mass business wire -nov 6 2018-ironwood pharmaceuticals inc nasdaq bowel syndrome cambridge olinciguat ironwood constipation abdominal pain iw-3718 ironwood ironwood phase iia asymptomatic ironwood pharmaceuticals gerd diabetic nephropathy hfpef abdominal distension severe diarrhea cic zurampic u s olinciguat peter hecht praliciguat ironwood r&d co allergan nephropathy fda achalasia praliciguat ironwood renal disease ironwoods gaap ironwood gaap allopurinol ironwood pharmaceuticals [V: inc] astrazeneca iw 3718 ironwood [ARG2: olinciguat ironwood mass]", "tags": ["O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "O", "B-V", "O", "O", "O", "O", "B-ARG2", "I-ARG2", "I-ARG2"]}], "words": ["ironwood", "pharmaceuticals", "provides", "third", "quarter", "2018", "investor", "update", "cambridge", "mass", "business", "wire", "-nov", "6", "2018-ironwood", "pharmaceuticals", "inc", "nasdaq", "bowel", "syndrome", "cambridge", "olinciguat", "ironwood", "constipation", "abdominal", "pain", "iw-3718", "ironwood", "ironwood", "phase", "iia", "asymptomatic", "ironwood", "pharmaceuticals", "gerd", "diabetic", "nephropathy", "hfpef", "abdominal", "distension", "severe", "diarrhea", "cic", "zurampic", "u", "s", "olinciguat", "peter", "hecht", "praliciguat", "ironwood", "r&d", "co", "allergan", "nephropathy", "fda", "achalasia", "praliciguat", "ironwood", "renal", "disease", "ironwoods", "gaap", "ironwood", "gaap", "allopurinol", "ironwood", "pharmaceuticals", "inc", "astrazeneca", "iw", "3718", "ironwood", "olinciguat", "ironwood", "mass"]}